Instrument Inactif

Communiqués Lpath, Inc. Nasdaq

Actions

US5489103060

Equipement, fournitures et distribution médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

04/04/23	Boston Scientific Corporation (NYSE:BSX) a finalisé l'acquisition d'Apollo Endosurgery, Inc. (NasdaqGM:APEN) auprès d'un groupe d'actionnaires.	CI
23/01/23	APOLLO ENDOSURGERY, INC. : Cowen moins optimiste	ZM

Communiqués

04/04/23	APOLLO ENDOSURGERY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, (form 8-K)	AQ
30/03/23	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
10/02/23	Apollo Endosurgery : Submission of Matters to a Vote of Security Holders - Form 8-K	PU
10/02/23	APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
29/12/22	APOLLO ENDOSURGERY, INC. : Unregistered Sale of Equity Securities (form 8-K)	AQ
28/12/22	Apollo Endosurgery : Merger Agreement - Form 8-K	PU
28/12/22	APOLLO ENDOSURGERY, INC. : Other Events (form 8-K)	AQ
05/12/22	Apollo Endosurgery To Be Acquired By Boston Scientific	AQ
30/11/22	APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
30/11/22	APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN	BU
29/11/22	APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
01/11/22	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/10/22	Apollo Endosurgery : THIRD AMENDMENT TO OFFICE LEASE AGREEMENT - Form 8-K	PU
06/10/22	APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
02/08/22	Apollo Endosurgery : Reports Record Global Revenue in Second Quarter 2022 - Form 8-K	PU
02/08/22	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
13/07/22	Apollo Endosurgery : FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG™ and Apollo REVISE™, New Endoscopic Systems for Patients with Obesity - Form 8-K	PU
13/07/22	APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/07/22	Apollo Endosurgery : Sharon O’Keefe Joins Apollo Endosurgery Board of Directors - Form 8-K	PU
06/07/22	APOLLO ENDOSURGERY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
14/06/22	APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
03/05/22	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
04/04/22	Apollo Endosurgery : Appoints Jeannette Bankes to Board of Directors - Form 8-K	PU
04/04/22	APOLLO ENDOSURGERY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
02/03/22	Apollo Endosurgery : to Participate in the Cowen Healthcare Conference	PU